tirzepatide sublingual - An Overview (2026) Tirzepatide Oral Rapid Dissolve Sublingual

Results After propensity score matching, those using GLP-1 RAs had a 12% higher probability of developing new chronic cough within 5 years of initiation than those using other second-line glucose-lowering agents

[1] [2] The primary mechanism of action of Wegovy involves mimicking the incretin hormone GLP-1, which regulates appetite and glucose metabolism

For most people, one of the first changes they observe is a shift in appetite

The results of these ongoing studies will inform future approval decisions

Thank you, and blessings on you and your team

Be sure to talk to your healthcare provider about any allergies you have